Article PDF
Avoid common mistakes on your manuscript.
References
Cooper C, Campion G, Melton LJ III. Hip fractures in the elderly: a worldwide projection. Osteoporosis Int 1992;2:285–9.
Melton LJ III. Hip fractures: a worldwide problem today and tomorrow. Bone 1993;14:S1–8.
Cummings SR, Nevitt MC. Epidemiology of hip fractures and falls. In: Kleerekoper M, Krane SM, editors. Clinical disorders of bone and mineral metabolism. New York: Mary Ann Liebert Inc., 1989:231–6.
Agnusdei D, Camporeale A, Gerardi D, Rossi S, Bocchi L, Gennari C. Trends in the incidence of hip fracture in Siena, Italy, from 1980 to 1991. Bone 1993;4:S31–4.
Poyser A. Osteoporotic fracture. MEDOS. Sandorama 1993, Special 1, Bone Disease and Fracture. 23–28.
Dequeker J, Tobing L, Rutten V, Guusens P, and the MEDOS Study Group. Relative risk factors for osteoporotic fracture: a pilot study of the MEDOS questionnaire. Clinical Rheumatol 1991;10:49–53.
Dequeker J, Ranstam J, Valsson J, Sigurgeirsson B, Allander E, and the MEDOS Study Group. The Mediterranean Osteoporosis (MEDOS) Study Questionnaire. Clin Rheumatol 1991;10:54–72.
Allander E, Lindahl BIB, and the MEDOS Group. The Mediter-rannean Osteoporosis Study (MEDOS): theoretical and practical issues of a major international project on hip fracture epidemiology. Bone 1993;14:S37–43.
Johnell O, Guilberg B, Allander E, Kanis JA, and the MEDOS Study Group. The apparent incidence of hip fracture in Europe: a study of national register sources. Osteoporosis Int 1992;2:298–302.
Elffors I, Allander E, Kanis JA, Guilberg B, Johnell O, Dequeker J, et al. The variable incidence of hip fracture in Southern Europe: the MEDOS Study. Osteoporosis Int 1994;4:253–63.
Miravet L, Chaumet-Riffaud, Ranstam J. Residential care and risk of proximal femur fracture. Bone 1993;14:S73–6.
Johnell O, Guilberg B, Kanis JA, Allander E, Elffors L, Dequeker J, et al. Risk factors for hip fracture in European women. J Bone Miner Res 1995;10:1802–15.
Dequeker J, Johnell O, and the MEDOS Study Group. Osteoarthritis protects against femoral neck fractures: the MEDOS Study experience. Bone 1993;14:S51–6.
Kanis JA, Johnell O, Guilberg B, Allander E, Dilsen G, Gennari C, et al. Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. BMJ 1992;305:1124–8.
Mazzuoli GF, Gennari C, Passeri M, Acca M, Camporeale A, Pioli G. Hip fracture in Italy: epidemiology and preventive efficacy of bone-active drugs. Bone 1993;14:S81–4.
Johnell O, Stenbeck M, Rosen M, Kanis JA. Therapeutic strategies in the prevention of hip fracture with drugs affecting bone metabolism. Bone 1993;14:S85–7.
Lyritis GP, Johnell O, Orthopaedic management of hip fracture. Bone 1993;14:S11–7.
Lyritis GP. Epidemiology and socio-economic cost of osteoporotic fractures in Greece. Calcif Tissue Int 1992;51:93–4.
Rapadao A, Gavilanes, EL, Castro N, Vallejo JC. Consequences of hip fracture. 1992 MEDOS Meeting, Lisbon, Portugal. Abstract book, p 21.
Author information
Authors and Affiliations
Consortia
Additional information
Collaborating Centres: G. Dilsen, Istanbul; C. Gennari, Siena; A. A. Lopes Vaz, Porto; G. Lyritis, Athens; G. D. Mazzuoli, Rome; L. Miravet, Paris; M. Passeri, Parma; R. Pérez-Cano, Seville; A. Rapado, Madrid; C. Ribot, Toulouse.Project Group: E. Allander, WHO Collaborating Centre for the Epidemiology of Rheumatic Conditions, Hudding; J. Dequeker, WHO Consultant, Leuven; J. A. Kanis, European Osteoporosis Foundation, Sheffield; N. Khaltaev, WHO Non-Communicable Diseases, Geneva.
Rights and permissions
About this article
Cite this article
Lyritis, G.P., the MEDOS Study Group. Epidemiology of hip fracture: The MEDOS study. Osteoporosis Int 6 (Suppl 3), 11–15 (1996). https://doi.org/10.1007/BF01623757
Issue Date:
DOI: https://doi.org/10.1007/BF01623757